These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17621263)

  • 1. Ski can negatively regulates macrophage differentiation through its interaction with PU.1.
    Ueki N; Zhang L; Hayman MJ
    Oncogene; 2008 Jan; 27(3):300-7. PubMed ID: 17621263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ski negatively regulates erythroid differentiation through its interaction with GATA1.
    Ueki N; Zhang L; Hayman MJ
    Mol Cell Biol; 2004 Dec; 24(23):10118-25. PubMed ID: 15542823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors.
    DeKoter RP; Walsh JC; Singh H
    EMBO J; 1998 Aug; 17(15):4456-68. PubMed ID: 9687512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PU.1 and the granulocyte- and macrophage colony-stimulating factor receptors play distinct roles in late-stage myeloid cell differentiation.
    Anderson KL; Smith KA; Perkin H; Hermanson G; Anderson CG; Jolly DJ; Maki RA; Torbett BE
    Blood; 1999 Oct; 94(7):2310-8. PubMed ID: 10498603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor.
    Dahl R; Walsh JC; Lancki D; Laslo P; Iyer SR; Singh H; Simon MC
    Nat Immunol; 2003 Oct; 4(10):1029-36. PubMed ID: 12958595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcriptional repressor GFI-1 antagonizes PU.1 activity through protein-protein interaction.
    Dahl R; Iyer SR; Owens KS; Cuylear DD; Simon MC
    J Biol Chem; 2007 Mar; 282(9):6473-83. PubMed ID: 17197705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell fate specification: role of master regulatory switch transcription factor PU.1 in differential hematopoiesis.
    Gangenahalli GU; Gupta P; Saluja D; Verma YK; Kishore V; Chandra R; Sharma RK; Ravindranath T
    Stem Cells Dev; 2005 Apr; 14(2):140-52. PubMed ID: 15910240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells.
    Rekhtman N; Radparvar F; Evans T; Skoultchi AI
    Genes Dev; 1999 Jun; 13(11):1398-411. PubMed ID: 10364157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding.
    Rogers JH; Owens KS; Kurkewich J; Klopfenstein N; Iyer SR; Simon MC; Dahl R
    Biomed Res Int; 2016; 2016():3983686. PubMed ID: 26942192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia.
    Burda P; Vargova J; Curik N; Salek C; Papadopoulos GL; Strouboulis J; Stopka T
    PLoS One; 2016; 11(3):e0152234. PubMed ID: 27010793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate.
    Bakri Y; Sarrazin S; Mayer UP; Tillmanns S; Nerlov C; Boned A; Sieweke MH
    Blood; 2005 Apr; 105(7):2707-16. PubMed ID: 15598817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CLEC5A (MDL-1) is a novel PU.1 transcriptional target during myeloid differentiation.
    Batliner J; Mancarelli MM; Jenal M; Reddy VA; Fey MF; Torbett BE; Tschan MP
    Mol Immunol; 2011 Jan; 48(4):714-9. PubMed ID: 21094529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PU.1 but not ets-2 is essential for macrophage development from embryonic stem cells.
    Henkel GW; McKercher SR; Yamamoto H; Anderson KL; Oshima RG; Maki RA
    Blood; 1996 Oct; 88(8):2917-26. PubMed ID: 8874188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy.
    Gu X; Hu Z; Ebrahem Q; Crabb JS; Mahfouz RZ; Radivoyevitch T; Crabb JW; Saunthararajah Y
    J Biol Chem; 2014 May; 289(21):14881-95. PubMed ID: 24695740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity.
    Curik N; Burda P; Vargova K; Pospisil V; Belickova M; Vlckova P; Savvulidi F; Necas E; Hajkova H; Haskovec C; Cermak J; Krivjanska M; Trneny M; Laslo P; Jonasova A; Stopka T
    Leukemia; 2012 Aug; 26(8):1804-11. PubMed ID: 22343522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression.
    Kihara-Negishi F; Yamamoto H; Suzuki M; Yamada T; Sakurai T; Tamura T; Oikawa T
    Oncogene; 2001 Sep; 20(42):6039-47. PubMed ID: 11593411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A composite C/EBP binding site is essential for the activity of the promoter of the IL-3/IL-5/granulocyte-macrophage colony-stimulating factor receptor beta c gene.
    van Dijk TB; Baltus B; Raaijmakers JA; Lammers JW; Koenderman L; de Groot RP
    J Immunol; 1999 Sep; 163(5):2674-80. PubMed ID: 10453008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
    Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A
    J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages.
    Marecki S; Atchison ML; Fenton MJ
    J Immunol; 1999 Sep; 163(5):2713-22. PubMed ID: 10453013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct interaction of PU.1 with oncogenic transcription factors reduces its serine phosphorylation and promoter binding.
    Seshire A; Rößiger T; Frech M; Beez S; Hagemeyer H; Puccetti E
    Leukemia; 2012 Jun; 26(6):1338-47. PubMed ID: 22105598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.